Aliens Mainstream Catholic Church Shocks Markets This Week
A surge of headlines about aliens and the Catholic Church is reshaping how investors think about religion, charity, a...
Which Budgeting Method Is Best For Me
Identify your ideal budgeting method by evaluating spending habits, goals, and flexibility. A straightforward guide to choosing wisely.
22,019 articles
Should Sell EZCORP After a Director Sells 10,000 Shares
When a EZCORP director unloads 10,000 shares, investors naturally wonder if it signals trouble or simply a routine di...
Elon Musk Becomes First: What This Milestone Means
A landmark milestone puts a spotlight on how market-valued wealth works. This article breaks down what elon musk beco...
Social Security Scheduled Money: What It Means for Retirement
A rising retirement burden and shifting policy outlook are reshaping how Americans view Social Security. Learn what t...
HYPE ETFs Quietly Pulled $161M in One Month Amid Crypto Bets
In the month since THYP debuted on Nasdaq, hype etfs quietly pulled $161 million in net inflows across the three US-t...
Oil Dips Toward $80 as Iran Deal Sparks Fed Cut Hopes
Oil prices retreat toward the $80 level after news of an Iran framework, easing supply fears and rekindling expectati...
This Economic Indicator Just Missed Expectations by a Mile
The latest monthly gauge shows a sharper-than-expected slowdown in manufacturing, fueling investor caution as the pat...
Wall Street Drifting Away From This Digital Monopoly
Netflix’s ad-supported tier is gaining traction and subscribers are rising, even as the broader market spurs a debate...
Roth Conversions Between $600,000: Tax Hedge Gains
A growing number of retirees are using the 62-to-70 Roth conversion window to move sizeable balances into Roth accoun...
Howard Marks: AI Stock Rally Has Speculative Tilt, He Warns
Howard Marks cautions that the AI stock rally may be more speculation than solid analysis, urging investors to anchor...
Anthropic’s IPO Pitch Faces Government Risk Amid Scrutiny
Anthropic aims to go public this fall, but mounting regulatory pressures risk undercutting its valuation. Investors a...
AbbVie Stock Will $300: Timing and Risks to Watch
AbbVie’s Q1 2026 results show strong immunology growth even as biosimilar challenges weigh on revenue. Analysts debat...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status